Cargando…

Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxido­phen­yl)ethyl­idene]hydrazin-1-yl­idene}(prop-2-en-1-ylsulfan­yl)meth­yl)­imino]­meth­yl}phenolato]vanadium(IV)

The V(IV) atom in the title complex, [V(C(19)H(17)N(3)O(2)S)O], is coordinated by two N and two O atoms of the dianionic tetra­dentate Schiff base ligand and the terminal oxide O atom. The N(2)O(3) donor set defines a square-pyramidal coordination geometry with the oxide O atom in the apical site. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Takjoo, Reza, Ng, Seik Weng, Tiekink, Edward R. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414106/
https://www.ncbi.nlm.nih.gov/pubmed/22904713
http://dx.doi.org/10.1107/S1600536812029819
_version_ 1782240152344592384
author Takjoo, Reza
Ng, Seik Weng
Tiekink, Edward R. T.
author_facet Takjoo, Reza
Ng, Seik Weng
Tiekink, Edward R. T.
author_sort Takjoo, Reza
collection PubMed
description The V(IV) atom in the title complex, [V(C(19)H(17)N(3)O(2)S)O], is coordinated by two N and two O atoms of the dianionic tetra­dentate Schiff base ligand and the terminal oxide O atom. The N(2)O(3) donor set defines a square-pyramidal coordination geometry with the oxide O atom in the apical site. Some buckling in the tetra­dentate ligand is indicated by the dihedral angle of 17.92 (19)° between the six-membered chelate rings. Supra­molecular chains are formed along the b axis via C—H⋯O contacts in the crystal. The chains are connected into a layer in the ab plane via C—H⋯π inter­actions. The atoms comprising the –SCH(2)—CH=CH(2) and methyl substituents were found to be disordered in a 0.916 (2):0.088 (2) ratio. The crystal studied was found to be twinned by nonmerohedry with a 28.1 (4)% minor twin component.
format Online
Article
Text
id pubmed-3414106
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-34141062012-08-17 Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxido­phen­yl)ethyl­idene]hydrazin-1-yl­idene}(prop-2-en-1-ylsulfan­yl)meth­yl)­imino]­meth­yl}phenolato]vanadium(IV) Takjoo, Reza Ng, Seik Weng Tiekink, Edward R. T. Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers The V(IV) atom in the title complex, [V(C(19)H(17)N(3)O(2)S)O], is coordinated by two N and two O atoms of the dianionic tetra­dentate Schiff base ligand and the terminal oxide O atom. The N(2)O(3) donor set defines a square-pyramidal coordination geometry with the oxide O atom in the apical site. Some buckling in the tetra­dentate ligand is indicated by the dihedral angle of 17.92 (19)° between the six-membered chelate rings. Supra­molecular chains are formed along the b axis via C—H⋯O contacts in the crystal. The chains are connected into a layer in the ab plane via C—H⋯π inter­actions. The atoms comprising the –SCH(2)—CH=CH(2) and methyl substituents were found to be disordered in a 0.916 (2):0.088 (2) ratio. The crystal studied was found to be twinned by nonmerohedry with a 28.1 (4)% minor twin component. International Union of Crystallography 2012-07-07 /pmc/articles/PMC3414106/ /pubmed/22904713 http://dx.doi.org/10.1107/S1600536812029819 Text en © Takjoo et al. 2012 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Takjoo, Reza
Ng, Seik Weng
Tiekink, Edward R. T.
Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxido­phen­yl)ethyl­idene]hydrazin-1-yl­idene}(prop-2-en-1-ylsulfan­yl)meth­yl)­imino]­meth­yl}phenolato]vanadium(IV)
title Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxido­phen­yl)ethyl­idene]hydrazin-1-yl­idene}(prop-2-en-1-ylsulfan­yl)meth­yl)­imino]­meth­yl}phenolato]vanadium(IV)
title_full Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxido­phen­yl)ethyl­idene]hydrazin-1-yl­idene}(prop-2-en-1-ylsulfan­yl)meth­yl)­imino]­meth­yl}phenolato]vanadium(IV)
title_fullStr Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxido­phen­yl)ethyl­idene]hydrazin-1-yl­idene}(prop-2-en-1-ylsulfan­yl)meth­yl)­imino]­meth­yl}phenolato]vanadium(IV)
title_full_unstemmed Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxido­phen­yl)ethyl­idene]hydrazin-1-yl­idene}(prop-2-en-1-ylsulfan­yl)meth­yl)­imino]­meth­yl}phenolato]vanadium(IV)
title_short Oxido[2-{(E)-[((1E)-{(E)-2-[1-(2-oxido­phen­yl)ethyl­idene]hydrazin-1-yl­idene}(prop-2-en-1-ylsulfan­yl)meth­yl)­imino]­meth­yl}phenolato]vanadium(IV)
title_sort oxido[2-{(e)-[((1e)-{(e)-2-[1-(2-oxido­phen­yl)ethyl­idene]hydrazin-1-yl­idene}(prop-2-en-1-ylsulfan­yl)meth­yl)­imino]­meth­yl}phenolato]vanadium(iv)
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414106/
https://www.ncbi.nlm.nih.gov/pubmed/22904713
http://dx.doi.org/10.1107/S1600536812029819
work_keys_str_mv AT takjooreza oxido2e1ee212oxidophenylethylidenehydrazin1ylideneprop2en1ylsulfanylmethyliminomethylphenolatovanadiumiv
AT ngseikweng oxido2e1ee212oxidophenylethylidenehydrazin1ylideneprop2en1ylsulfanylmethyliminomethylphenolatovanadiumiv
AT tiekinkedwardrt oxido2e1ee212oxidophenylethylidenehydrazin1ylideneprop2en1ylsulfanylmethyliminomethylphenolatovanadiumiv